DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erythrocin (Erythromycin) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Erythrocin (Erythromycin). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (11)
     Hepatic Function Abnormal (2)Hepatic Failure (2)Respiratory Failure (2)more >>

Cases resulting in a serious event (10)
     Hepatic Function Abnormal (2)Hepatic Failure (2)Respiratory Failure (2)more >>

Cases resulting in death (5)
     Hepatic Failure (2)Respiratory Failure (2)Hepatitis Fulminant (2)more >>

Cases resulting in life threatening events (1)
     Hepatic Function Abnormal (1)Hepatic Failure (1)

Cases resulting in hospitalization (2)
     Pneumonia Aspiration (1)Hypercapnia (1)Hyperglycaemia (1)more >>

Cases resulting in other serious reactions (3)
     Drug Eruption (1)Nasopharyngitis (1)Oral Mucosal Disorder (1)more >>

Adverse event in male receiving Erythrocin (Erythromycin)

Reported by a physician from Japan on 2007-10-30

Patient: male

Adverse reactions / side effects: Interstitial Lung Disease, Respiratory Failure, Lung Abscess

Adverse event resulted in: death

Suspect drug(s):
Finibax

Finibax
    Indication: Lung Abscess

Norvasc
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Itraconazole
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Zantac
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Ferromia
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Erythrocin
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Biofermin R
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Sucralfate
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Slow-K
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Mucosta
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Juzen-Taiho-TO
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Cravit



Adverse event in 79 year old male receiving Erythrocin (Erythromycin)

Reported by a consumer/non-health professional from United States on 2007-07-25

Patient: 79 year old male, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Drug Ineffective

Suspect drug(s):
Erythrocin
    Indication: Eye Irritation
    Start date: 2007-04-03
    End date: 2007-04-08

Erythrocin
    Indication: Eye Pruritus
    Start date: 2007-04-03
    End date: 2007-04-08

Erythrocin
    Indication: Asthenopia
    Start date: 2007-04-03
    End date: 2007-04-08

Other drugs received by patient: Nasarel; Omeprazole; Terazosin HCL



Adverse event in 92 year old male receiving Erythrocin (Erythromycin)

Reported by a pharmacist from Japan on 2007-07-13

Patient: 92 year old male, weighing 42.0 kg (92.4 pounds)

Adverse reactions / side effects: Hepatic Function Abnormal

Adverse event resulted in: hospitalization

Suspect drug(s):
Meropenem
    Indication: Pneumonia
    Start date: 2006-12-06
    End date: 2006-12-11

Unasyn
    Indication: Pneumonia
    Start date: 2006-12-04
    End date: 2006-12-07

Erythrocin
    Indication: Pneumonia
    Start date: 2006-12-04
    End date: 2006-12-06

Meropenem
    Indication: Pneumonia
    Start date: 2006-12-06
    End date: 2006-12-11

Unasyn
    Indication: Pneumonia
    Start date: 2006-12-04
    End date: 2006-12-07

Erythrocin Lactobionate
    Indication: Pneumonia
    Start date: 2006-12-04
    End date: 2006-12-06

Other drugs received by patient: Berizym; Pantosin; Epadel-S; Heavy K MAG-G; Paediatric Bufferin; Berizym; Pantosin; Epadel-S; Heavy K MAG-G; Paediatric Bufferin



Adverse event in 50 year old male receiving Erythrocin (Erythromycin)

Reported by a pharmacist from Japan on 2007-06-28

Patient: 50 year old male

Adverse reactions / side effects: Hepatic Function Abnormal, Hepatic Failure

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Erythrocin (Erythromycin)

Other drugs received by patient: Ambroxol Hydrochloride; Sodium Alginate; Ranitidine Hydrochloride; Bromhexine Hydrochloride; Warfarin Potassium



Adverse event in 79 year old male receiving Erythrocin (Erythromycin)

Reported by a physician from Japan on 2007-05-31

Patient: 79 year old male, weighing 48.0 kg (105.6 pounds)

Adverse reactions / side effects: Pneumonia Aspiration, Hypercapnia, Hyperglycaemia, Urine Output Decreased, Drug Interaction, Delirium, Herpes Zoster, Myoclonus, Renal Impairment, Gastrointestinal Fistula, Altered State of Consciousness, Neuralgia

Adverse event resulted in: hospitalization

Suspect drug(s):
Prograf
    Dosage: see image
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2007-01-21
    End date: 2007-02-17

Prograf
    Dosage: see image
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2007-03-07

Seroquel
    Dosage: 75 mg, bid, oral
    Administration route: Oral
    Indication: Delirium
    Start date: 2007-02-06
    End date: 2007-02-17

Erythrocin
    Dosage: 150 mg, tid, oral
    Administration route: Oral
    Indication: Bronchitis Chronic
    Start date: 2007-01-16

Other drugs received by patient: Prednisolone; Symmetrel; Mobic; Mucosolvan (Ambroxol Hydrochloride) Tablet; Acinon (Nizatidine) Capsule; Mytelase (Ambenonium Chloride) Tablet; Risedronate Sodium; Racol PER Oral NOS; Sword (Prulifloxacin) Tablet; Aleviatin (Phenytoin) Injection



Adverse event in 12 month old female receiving Erythrocin (Erythromycin)

Reported by a physician from Japan on 2007-03-29

Patient: 12 month old female, weighing 9.0 kg (19.8 pounds)

Adverse reactions / side effects: Cardio-Respiratory Arrest

Adverse event resulted in: death

Suspect drug(s):
Tamiflu
    Dosage: drug reported as dry syrup. drug name reported as tamiflu dry syrup 3%.
    Administration route: Oral
    Indication: Influenza
    Start date: 2006-02-11
    End date: 2006-02-11

Erythrocin
    Administration route: Oral
    Indication: Bronchitis
    Start date: 2006-02-10
    End date: 2006-02-11

Polaramine
    Administration route: Oral
    Indication: Bronchitis
    Start date: 2006-02-10
    End date: 2006-02-11

Mucosal
    Administration route: Oral
    Indication: Bronchitis
    Start date: 2006-02-10
    End date: 2006-02-11

Asverin
    Administration route: Oral
    Indication: Bronchitis
    Start date: 2006-02-10
    End date: 2006-02-11

Hokunalin
    Administration route: Topical
    Indication: Bronchitis
    Start date: 2006-02-10
    End date: 2006-02-11



Adverse event in 61 year old female receiving Erythrocin (Erythromycin)

Reported by a individual with unspecified qualification from Spain on 2007-03-19

Patient: 61 year old female

Adverse reactions / side effects: Drug Eruption, Glossodynia, Nasopharyngitis, Oral Mucosal Disorder, Dermatitis Bullous, Skin Test Positive, Skin Hyperpigmentation, Erythema, Blister

Suspect drug(s):
Ibuprofen
    Dosage: df po
    Administration route: Oral
    Indication: Nasopharyngitis

Ibuprofen
    Dosage: df po
    Administration route: Oral
    Indication: Tooth Infection

Erythrocin
    Dosage: df po
    Administration route: Oral
    Indication: Tooth Infection

Ibuprofen
    Dosage: df td
    Indication: Skin Test

Erythrocin
    Dosage: df td
    Indication: Skin Test



Adverse event in 66 year old male receiving Erythrocin (Erythromycin)

Reported by a pharmacist from United Kingdom on 2007-03-09

Patient: 66 year old male, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Dizziness, Fall

Suspect drug(s):
Erythrocin (Erythromycin)

Other drugs received by patient: Amoxicillin; Codeine Phosphate; Pholcodine



Adverse event in 11 year old female receiving Erythrocin (Erythromycin)

Reported by a individual with unspecified qualification from Japan on 2007-02-12

Patient: 11 year old female

Adverse reactions / side effects: Oral Discomfort, Dental Operation, Gingivectomy, Gingival Hypertrophy

Suspect drug(s):
Tegretol
    Dosage: 100 mg/day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1997-10-01

Tegretol
    Dosage: 500 mg/day
    Administration route: Oral

Tegretol
    Dosage: 50 mg/day
    Administration route: Oral
    End date: 2000-05-01

Depakene
    Dosage: 100 mg/day

Primidone

Cercine

Dopaston

Dantrium

Mystan
    Dosage: unk, unk
    Start date: 1997-01-01

Erythrocin

Spelear

Neuzym

Gasmotin

Sodium Chloride

Other drugs received by patient: Aleviatin



Adverse event in female receiving Erythrocin (Erythromycin)

Reported by a physician from Japan on 2007-02-02

Patient: female

Adverse reactions / side effects: Respiratory Failure, Depressed Level of Consciousness, Hepatic Failure, Hepatitis Fulminant

Adverse event resulted in: death

Suspect drug(s):
Clarithromycin
    Administration route: Oral
    Indication: Pneumonia
    Start date: 2006-10-02
    End date: 2006-10-16

Erythrocin
    Indication: Pneumonia
    Start date: 2006-10-17
    End date: 2006-10-19

Cefmetazole Sodium
    Indication: Pneumonia
    Start date: 2006-09-29
    End date: 2006-10-05

Meropenem
    Indication: Pneumonia
    Start date: 2006-10-06
    End date: 2006-10-19

Doripenem Hydrate
    Indication: Pneumonia
    Start date: 2006-10-18
    End date: 2006-10-19

Doxapram Hydrochloride
    Indication: Respiratory Failure
    Start date: 2006-10-18
    End date: 2006-10-19



Adverse event in 78 year old female receiving Erythrocin (Erythromycin)

Reported by a physician from Japan on 2007-01-23

Patient: 78 year old female

Adverse reactions / side effects: Hepatitis Fulminant

Adverse event resulted in: death

Suspect drug(s):
Erythrocin
    Indication: Drug USE FOR Unknown Indication

Doxapram Hydrochloride Hydrate
    Indication: Drug USE FOR Unknown Indication

Doripenem Hydrate
    Indication: Drug USE FOR Unknown Indication

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009